- +106.7% price growth over the last year
- Excellent financial health (Piotroski 7/9)
- Beat earnings estimates in 3 of the last 4 quarters
Green day on Tuesday for Amneal Pharmaceuticals, Inc. stock after gaining 0.768%
(Updated on Jul 07, 2026)
The Amneal Pharmaceuticals, Inc. stock price gained 0.768% on the last trading day (Tuesday, 7th Jul 2026), rising from $16.92 to $17.05. During the last trading day the stock fluctuated 3.23% from a day low at $16.88 to a day high of $17.42. The price has risen in 7 of the last 10 days and is up by 5.83% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 183 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $30.96 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.91% during the next 3 months and, with a 90% probability hold a price between $19.63 and $24.47 at the end of this 3-month period.
AMRX Signals & Forecast
The Amneal Pharmaceuticals, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $17.13. On a fall, the stock will find some support from the long-term average at approximately $14.82. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 25, 2026, and so far it has fallen -1.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Amneal Pharmaceuticals, Inc. stock
Amneal Pharmaceuticals, Inc. finds support from accumulated volume at $16.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.545 between high and low, or 3.23%. For the last week, the stock has had daily average volatility of 2.87%.
Our recommended stop-loss: $16.35 (-4.09%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 7 days ago.)
Trading Expectations (AMRX) For The Upcoming Trading Day Of Wednesday 8th
For the upcoming trading day on Wednesday, 8th we expect Amneal Pharmaceuticals, Inc. to open at $17.12, and during the day (based on 14 day Average True Range), to move between $16.78 and $17.32, which gives a possible trading interval of +/-$0.542 (+/-3.23%) up or down from last closing price. If Amneal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 3.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $17.29 (1.41%) than the support at $16.34 (4.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Amneal Pharmaceuticals, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amneal Pharmaceuticals, Inc. stock to perform well in the short-term.
Current score:
2.977
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 8, 2026 - $17.12 ( 0.381%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
AMRX Performance
Trading levels for AMRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 17.66 | 3.58% |
| R2 | 17.45 | 2.36% |
| R1 | 17.32 | 1.60% |
| Price | 17.05 | |
| S1 | 16.91 | -0.84% |
| S2 | 16.78 | -1.59% |
| S3 | 16.57 | -2.82% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 17.32 | 1.58% |
| R2 | 17.31 | 1.52% |
| R1 | 17.29 | 1.41% |
| Price | 17.05 | |
| S1 | 16.34 | -4.16% |
| S2 | 15.32 | -10.15% |
| S3 | 12.82 | -24.81% |
FAQ
Click here for our free guide on how to buy Amneal Pharmaceuticals, Inc. Stock.
Buy AMRX